Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest

Glenn M. Eastwood(Intensive Care Society), Alistair Nichol(University College Dublin), Carol Hodgson(The Alfred Hospital), Rachael Parke(University of Auckland), Shay McGuinness(University College Dublin), Niklas Nielsen(Lund University), Stephen Bernard(Intensive Care Society), Markus B. Skrifvars(Intensive Care Society), Dion Stub(Intensive Care Society), Fabio Silvio Taccone(Université Libre de Bruxelles), John S. Archer(Intensive Care Society), Demetrios J. Kutsogiannis(Christchurch Hospital), Josef Dankiewicz(Intensive Care Society), Gisela Lilja(Intensive Care Society), Tobias Cronberg(Intensive Care Society), Hans Kirkegaard(University of Helsinki), Gilles Capellier(Intensive Care Society), Giovanni Landoni(Vita-Salute San Raffaele University), Janneke Horn(Intensive Care Society), Theresa M. Olasveengen(University of Oslo), Yaseen M. Arabi(King Saud bin Abdulaziz University for Health Sciences), Yew Woon Chia(Nanyang Technological University), Andrej Markota(Intensive Care Society), Matthias Hænggi(Intensive Care Society), Matt P. Wise(University Hospital of Wales), Anders Morten Grejs(Aarhus University), Steffen Christensen(Intensive Care Society), Heidi Munk-Andersen(Intensive Care Society), Asger Granfeldt(University of Helsinki), Geir Øystein Andersen(Intensive Care Society), Eirik Qvigstad(Intensive Care Society), Arnljot Flaa(Intensive Care Society), Matthew Thomas(Bristol Royal Infirmary), Katie Sweet(Bristol Royal Infirmary), Jeremy Bewley(Bristol Royal Infirmary), Minna Bäcklund(Intensive Care Society), Marjaana Tiainen(University of Helsinki), Manuela Iten(University of Helsinki), Anja Levis(Vita-Salute San Raffaele University), Leah Peck(Intensive Care Society), James Walsham(The University of Queensland), Adam M. Deane(The Royal Melbourne Hospital), Angaj Ghosh(University of Helsinki), Filippo Annoni(Intensive Care Society), Yan Chen(Intensive Care Society), David Knight(Christchurch Hospital), Eden Lesona(Auckland City Hospital), Haytham Tlayjeh(King Saud bin Abdulaziz University for Health Sciences), Franc Svenšek(Intensive Care Society), Peter J. McGuigan(Queen's University Belfast), Jade Cole(University Hospital of Wales), David Pogson(National University of Singapore), Matthias P. Hilty(Intensive Care Society), Joachim Düring(Intensive Care Society), Michael Bailey(Intensive Care Society), Eldho Paul(Intensive Care Society), Bridget Ady(Intensive Care Society), Kate Ainscough(University College Dublin), Anna Hunt(Auckland City Hospital), Sinéad Monahan(University College Dublin), Tony Trapani(Intensive Care Society), Ciara Fahey(University College Dublin), Rinaldo Bellomo(The Royal Melbourne Hospital)
New England Journal of Medicine
June 15, 2023
Cited by 130Open Access
Full Text

Abstract

Guidelines recommend normocapnia for adults with coma who are resuscitated after out-of-hospital cardiac arrest. However, mild hypercapnia increases cerebral blood flow and may improve neurologic outcomes. Download a PDF of the Research Summary. We randomly assigned adults with coma who had been resuscitated after out-of-hospital cardiac arrest of presumed cardiac or unknown cause and admitted to the intensive care unit (ICU) in a 1:1 ratio to either 24 hours of mild hypercapnia (target partial pressure of arterial carbon dioxide [Paco2], 50 to 55 mm Hg) or normocapnia (target Paco2, 35 to 45 mm Hg). The primary outcome was a favorable neurologic outcome, defined as a score of 5 (indicating lower moderate disability) or higher, as assessed with the use of the Glasgow Outcome Scale–Extended (range, 1 [death] to 8, with higher scores indicating better neurologic outcome) at 6 months. Secondary outcomes included death within 6 months. A total of 1700 patients from 63 ICUs in 17 countries were recruited, with 847 patients assigned to targeted mild hypercapnia and 853 to targeted normocapnia. A favorable neurologic outcome at 6 months occurred in 332 of 764 patients (43.5%) in the mild hypercapnia group and in 350 of 784 (44.6%) in the normocapnia group (relative risk, 0.98; 95% confidence interval [CI], 0.87 to 1.11; P=0.76). Death within 6 months after randomization occurred in 393 of 816 patients (48.2%) in the mild hypercapnia group and in 382 of 832 (45.9%) in the normocapnia group (relative risk, 1.05; 95% CI, 0.94 to 1.16). The incidence of adverse events did not differ significantly between groups. In patients with coma who were resuscitated after out-of-hospital cardiac arrest, targeted mild hypercapnia did not lead to better neurologic outcomes at 6 months than targeted normocapnia. (Funded by the National Health and Medical Research Council of Australia and others; TAME ClinicalTrials.gov number, NCT03114033.) QUICK TAKE VIDEO SUMMARYMild Hypercapnia after Out-of-Hospital Cardiac Arrest 02:19


Related Papers

No related papers found

Powered by citation graph analysis